Status:
RECRUITING
3DUS Imaging of Needles in Gynecological Brachytherapy
Lead Sponsor:
Western University, Canada
Conditions:
Gynecologic Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Brachytherapy treatment in gynecological cancers is an essential component to delivering adequate doses of radiation to a tumour while sparing normal tissue. Interstitial or intra-cavitary brachythera...
Eligibility Criteria
Inclusion
- Females of age eighteen (18) or greater.
- Patients with locally advanced or recurrent gynecological malignancies who are offered interstitial or ring and tandem brachytherapy treatment. These typically would include patients with primary or recurrent vaginal cancers, endometrial cancers or cervical cancers. Histologies of these cancers are typically adenocarcinomas or squamous cell carcinomas
Exclusion
- • Above patients who are not offered interstitial brachytherapy as a treatment modality
Key Trial Info
Start Date :
October 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT04705467
Start Date
October 15 2022
End Date
June 1 2026
Last Update
April 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
London Regional Cancer Program, Victoria Hospital
London, Ontario, Canada, N6A 5W9